Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease.
J Diabetes Complications
; 37(10): 108610, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37722211
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Non-alcoholic Fatty Liver Disease
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
J Diabetes Complications
Journal subject:
ENDOCRINOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
China